{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:34:54Z","timestamp":1777955694621,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Comparison of a patient\u2019s abnormal serum creatinine result to an earlier value is fundamental to differentiating Acute Kidney Injury (AKI) from Chronic Kidney Disease (CKD), and is the first step in electronic AKI detection systems. For those patients in whom a baseline serum creatinine is unavailable, some systems generate a warning message to highlight the elevated serum creatinine but without distinguishing AKI from CKD (a \u201c?AKI?CKD\u201d warning). We aimed to determine demographic characteristics of this group, the proportion who had a first presentation of AKI, their clinical outcomes, and how these alert messages translate into subsequent biochemical testing and follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective cohort analysis of adult patients with serum creatinine testing at University Hospitals of Leicester during 2019. Using the NHS England AKI detection algorithm, we identified patients with AKI Warning Test Scores (WTS) and \u201c?AKI?CKD\u201d warnings. The \u201c?AKI?CKD\u201d cohort was classified as probable AKI, probable CKD, or no follow-up result, based on subsequent serum creatinine measurements. Survival (90-day and 1-year) was analysed with Kaplan\u2013Meier methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 3,464 patients with \u201c?AKI?CKD\u201d warnings, 8.5% were probable AKI, 59.4% probable CKD, and 32.0% had no follow-up test. Probable AKI patients were younger (median age 71 versus 76 years) and more often hospitalised at warning time (56% versus 15%). One-year survival was lower in probable AKI (72%) compared to probable CKD (88%) or no follow-up (89%). Probable AKI survival was similar to AKI WTS stage 1 but better than stages 2\u20133. Extending baseline serum creatinine look-back to 426 days changed categorisation minimally (\u2264\u20092%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight that the major feature of the \u201c?AKI?CKD\u201d classification is not simply misclassification between AKI and CKD, but the variability of clinical response, with one-third of patients receiving no subsequent serum creatinine test. Most patients flagged as \u201c?AKI?CKD\u201d likely have CKD rather than AKI, and this, coupled with comparable outcomes of the probable AKI group to early-stage AKI, suggests minimal missed population-level AKI detection. However, one-third lacked follow-up testing, highlighting missed opportunities to identify CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-04758-8","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:43:08Z","timestamp":1769521388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinguishing AKI from CKD: outcomes and characteristics of patients with abnormal serum creatinine and no known baseline"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5772-9759","authenticated-orcid":false,"given":"Esther","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Casula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosie","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Tilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas M.","family":"Selby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Medcalf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"4758_CR1","doi-asserted-by":"crossref","unstructured":"Selby N, et al. Design and Rationale of \u2018Tackling Acute Kidney Injury\u2019, a Multicentre Quality Improvement Study. Nephron. 2016;134(3).","DOI":"10.1159\/000447675"},{"key":"4758_CR2","doi-asserted-by":"crossref","unstructured":"Sawhney S, et al. Intermediate and Long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis. 2017;69(1).","DOI":"10.1053\/j.ajkd.2016.05.018"},{"key":"4758_CR3","doi-asserted-by":"crossref","unstructured":"Semogas IK, et al. Investigating acute kidney injury in primary care. BMJ. 2019;365.","DOI":"10.1136\/bmj.l4007"},{"key":"4758_CR4","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) AKIWG. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Supplements. 2012;2(1):1\u2013138."},{"key":"4758_CR5","doi-asserted-by":"crossref","unstructured":"Selby N, et al. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients - PubMed. Clin J Am Soc Nephrology: CJASN. 2012;7(4).","DOI":"10.2215\/CJN.08970911"},{"key":"4758_CR6","doi-asserted-by":"crossref","unstructured":"Selby N et al. An Organizational-Level program of intervention for AKI: A pragmatic stepped wedge cluster randomized trial. J Am Soc Nephrol, 2019. 30(3).","DOI":"10.1681\/ASN.2018090886"},{"issue":"1783","key":"4758_CR7","first-page":"25","volume":"259","author":"K Larmour","year":"2015","unstructured":"Larmour K, Maxwell AP. Early intervention can improve outcomes in acute kidney injury. Practitioner. 2015;259(1783):25\u20138.","journal-title":"Practitioner"},{"key":"4758_CR8","unstructured":"NHS England. NHS England patient safety alert. 2014. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2014\/03\/psa-med-error.pdf"},{"issue":"3","key":"4758_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ekir.2021.01.030","volume":"6","author":"J Bouchard","year":"2021","unstructured":"Bouchard J. Estimating baseline serum creatinine for assessing acute kidney injury: not a one size fits all approach. Kidney Int Rep. 2021;6(3):562\u20134.","journal-title":"Kidney Int Rep"},{"key":"4758_CR10","unstructured":"Algorithm for detecting Acute Repeat Kidney Injury (AKI) based on serum creatinine changes with time. 2014."},{"key":"4758_CR11","unstructured":"NHS England Algorithm. for detecting Acute Repeat Kidney Injury (AKI) based on serum creatinine changes with time. Members of the consensus group whose names and meeting report can be accessed on: http:\/\/www.acb.org.uk\/docs\/E-Alerts_for_AKI_meeting_statement. 2014."},{"issue":"7","key":"4758_CR12","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2215\/CJN.08531109","volume":"5","author":"JW Pickering","year":"2010","unstructured":"Pickering JW, Endre ZH. Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Clin J Am Soc Nephrol. 2010;5(7):1165\u201373.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4758_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ekir.2020.12.020","volume":"6","author":"DJ Cooper","year":"2021","unstructured":"Cooper DJ, et al. An evaluation of commonly used surrogate baseline creatinine values to classify AKI during acute infection. Kidney Int Rep. 2021;6(3):645\u201356.","journal-title":"Kidney Int Rep"},{"issue":"9","key":"4758_CR14","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/ndt\/gfp159","volume":"24","author":"SM Bagshaw","year":"2009","unstructured":"Bagshaw SM, et al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transpl. 2009;24(9):2739\u201344.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"4758_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13054-020-02886-7","volume":"24","author":"R Wiersema","year":"2020","unstructured":"Wiersema R, et al. Different applications of the KDIGO criteria for AKI lead to different incidences in critically ill patients: a post hoc analysis from the prospective observational SICS-II study. Crit Care. 2020;24(1):164.","journal-title":"Crit Care"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04758-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04758-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04758-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:14:19Z","timestamp":1771420459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04758-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4758"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04758-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UK Renal Registry holds REC approval (21\/NE\/0045) covering data collection and research. Use of these data was conducted under the UKRR\u2019s Sect.\u00a0251 approvals granted by the Health Research Authority\u2019s Confidentiality Advisory Group (CAG) (CAG references 16\/CAG\/0153 (non-research) and 16\/CAG\/0064 (research)). The need for informed consent to participate was waived by the CAG under this Sect.\u00a0251 approval. This study used data provided by University Hospitals of Leicester as part of their submissions to the UKRR audit of AKI, these data were then used for research. Patient data were linked to Hospital Episode Statistics (HES) and Office for National Statistics (ONS) mortality records held by NHS England to obtain follow-up information. This linkage was performed securely under all required ethical and legal approvals. No patient contact or intervention was involved. Individual patient consent was therefore not required for this study. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Individual informed consent for publication was waived by the relevant ethics committee under the approvals detailed in the ethics statement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have completed the ICMJE disclosure form. The main author is employed by the UK Kidney Association (UKKA) and is undertaking a part-time PhD at the University of Bristol, supported through funding from the UKKA. No additional financial support, honoraria, royalties, or commercial funding were received for the conduct of this study or preparation of the manuscript. The authors declare no other financial or non-financial relationships or activities that could appear to have influenced the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial and non-financial relationships and activities"}},{"value":"Artificial intelligence tools (Perplexity AI, Grammarly) were used solely to assist with grammar, language, and stylistic editing during manuscript preparation. No generative AI tools were used for data analysis, interpretation, or substantive content generation. All authors reviewed and approved the final text, and accept responsibility for its content.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI use"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}